Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Anderson

Pediatrics High Point, NC Medical Doctor

NPI 1952348146 CMS profile 1159380

4515 Premier Dr, Suite 203, High Point, NC 27265

Open in the dashboard

General payments

$669,094

1,421 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Anderson of High Point, NC is reported in the CMS Open Payments database as having received $669,094 across 1,421 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $98,283 160
2024 General $95,629 260
2023 General $237,311 480
2022 General $104,300 206
2021 General $82,755 195
2020 General $12,836 39
2019 General $37,979 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Anderson
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to James Anderson were reported at $98,283. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year James Anderson Pediatrics median Middle half National median
2019 $37,979 $86 $31–$183 $163
2020 $12,836 $49 $22–$110 $114
2021 $82,755 $68 $27–$158 $132
2022 $104,300 $77 $30–$173 $149
2023 $237,311 $88 $33–$190 $160
2024 $95,629 $94 $34–$206 $164
2025 $98,283 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $238,050 370 payments
  2. Ironshore Pharmaceuticals Inc. $195,164 457 payments
  3. Supernus Pharmaceuticals, Inc. $179,670 426 payments
  4. Collegium Pharmaceutical, Inc. $48,980 66 payments
  5. Neos Therapeutics, LP $6,062 95 payments
  6. Aytu BioScience, Inc $1,000 3 payments
  7. Noven Pharmaceuticals, Inc. $120 1 payment
  8. Novo Nordisk Inc $19 1 payment
  9. Pfizer Inc. $15 1 payment
  10. Dexcom, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $463,557 242 payments
  2. Travel and Lodging $82,763 426 payments
  3. Consulting Fee $61,828 24 payments
  4. Honoraria $39,600 16 payments
  5. Food and Beverage $21,346 713 payments
Products named General payments · program years 2019–2025
  1. Azstarys $238,050 370 payments
  2. QELBREE Psychology $101,034 243 payments
  3. JORNAY PM Central Nervous System Stimulant $96,620 304 payments
  4. Qelbree Viloxazine Hydrochloride $74,280 169 payments
  5. JORNAY PM Central Nervous Stimulant ADHD $65,407 81 payments
  6. Jornay PM Adhd $48,980 66 payments
  7. Jornay PM 20mg capsules (Bottle of 100) $33,137 72 payments
  8. COTEMPLA XR-ODT $6,179 54 payments
  9. Adzenys XR-ODT Adhd $5,090 35 payments
  10. Adzenys XR-ODT Adhd $1,276 54 payments
  11. Other $931 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,421 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record